ConductScience.org, home

Paper38242

Potent and specific inhibition of glutathione synthesis by buthionine sulfoximine (S-n-butyl homocysteine sulfoximine).

Griffith OW and 1 other. J Biol Chem, 1979. Cited by 1,462 papers, by iCite.

Cite this record

ConductScience Library. Potent and specific inhibition of glutathione synthesis by buthionine sulfoximine (S-n-butyl homocysteine sulfoximine). Papers, record 38242. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38242

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Potent and specific inhibition of glutathione synthesis by buthionine sulfoximine (S-n-butyl homocysteine sulfoximine).
PubMed
Journal
J Biol Chem
PubMed
Year
1979
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
1,462
iCite
Relative citation ratio, by iCite
38.3
iCite
Revised in PubMed
2021-02-10
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Griffith OWO W
2Meister AA

Source PubMed

Download CSV of authors

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Glutamate-Cysteine LigaseMajor topic
GlutathioneMajor topic
Methionine SulfoximineMajor topic
Peptide SynthasesMajor topic
Kinetics
Structure-Activity Relationship

Cited by413

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1,462 citations.

PMIDTitleJournalYearIn PapersSource
42792126Skin Histology of Pithecopus spp. and Modulation of Glutathione Status by the Antioxidant Tryptophyllin PaT-2.Antioxidants (Basel)2026https://conductscience.org/library/papers/42792126PubMed
42762415NRF2 signaling drives chemoresistance in NSCLC and glioblastoma.Mol Cell Biochem2026https://conductscience.org/library/papers/42762415PubMed
42466747Engineered Substrates for a Sulfurtransferase Enhance Endogenous Hydropersulfides and Inhibit Ferroptosis.Angew Chem Int Ed Engl2026https://conductscience.org/library/papers/42466747PubMed
42412619Targeting Cystine Addiction Suppresses Breast Cancer Lung Metastasis.Cancer Res2026https://conductscience.org/library/papers/42412619PubMed
42377466Peroxisomal catalase and plasmalogen biosynthesis protect from oxidative stress in Barth syndrome cardiomyopathy.Basic Res Cardiol2026https://conductscience.org/library/papers/42377466PubMed
42232504Targeting the Mitochondrial Phenotype in Cockayne Syndrome Patient Cells: From Bioenergetic Fragility to Pharmacologic Rescue.bioRxiv2026https://conductscience.org/library/papers/42232504PubMed
41959261Systematic Evaluation Defines the Limits of Ferroptosis in Cancer Therapy.bioRxiv2026https://conductscience.org/library/papers/41959261PubMed
41692318Deuterated polyunsaturated fatty acids alleviate in vitro skeletal muscle dysfunction induced by oxidative stress.Free Radic Biol Med2026https://conductscience.org/library/papers/41692318PubMed
41613499The Hallmarks of Ferroptosis.Annu Rev Cancer Biol2019https://conductscience.org/library/papers/41613499PubMed
41523578ROS-activatable Prodrug of Doxazolidine as Novel Cancer Therapy Paradigm.Adv Ther (Weinh)2024https://conductscience.org/library/papers/41523578PubMed
41509286Deuterated Polyunsaturated Fatty Acids Alleviate In Vitro Skeletal Muscle Dysfunction Induced by Oxidative Stress.bioRxiv2025https://conductscience.org/library/papers/41509286PubMed
41501350Tocotrienols exhibit superior ferroptosis inhibition over tocopherols.Sci Rep2026https://conductscience.org/library/papers/41501350PubMed
41373985Protective Role of Ginsenoside F1-Enriched Extract (SGB121) in Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD).Nutrients2025https://conductscience.org/library/papers/41373985PubMed
41347142Loss of Nocturnin increases neuronal viability in oxidative stress conditions.Front Neurosci2025https://conductscience.org/library/papers/41347142PubMed
41333220The implication of aberrant NRF2 activation in management of female cancers.Front Oncol2025https://conductscience.org/library/papers/41333220PubMed
41290624Non-canonical roles of Keap1/Nrf2 in regulating quiescence and early activation in adult muscle stem cells.Nat Commun2025https://conductscience.org/library/papers/41290624PubMed
40826242Prospects for ferroptosis therapies in cancer.Nat Cancer2025https://conductscience.org/library/papers/40826242PubMed
40823867Synergistic activity of RSL3 and Pyrimethamine to inhibit the proliferation of Plasmodium falciparum.Antimicrob Agents Chemother2025https://conductscience.org/library/papers/40823867PubMed
40772229Inhibiting the RNA helicase DDX3X in Burkitt lymphoma induces oxydative stress and impedes tumor progression in xenografts.Front Cell Dev Biol2025https://conductscience.org/library/papers/40772229PubMed
40681773PHLPP1 regulates region-specific astroglial mitochondrial fission in response to oxidative stress in the male rat hippocampus.Sci Rep2025https://conductscience.org/library/papers/40681773PubMed

See all 413 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/38242

GET https://conductscience.org/api/papers/v1/38242/cited_by?page=2